Pluri (PLUR) Other Working Capital Changes (2010 - 2025)
Pluri (PLUR) posted quarterly Other Working Capital Changes of -$16000.0 for Q4 2025, up 61.9% year-over-year from -$9882.4 in Q4 2024, and up 81.82% quarter-over-quarter from -$88000.0 in Q3 2025.
Pluri (PLUR) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Other Working Capital Changes for 8 consecutive years, with -$16000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 61.9% year-over-year to -$16000.0; the TTM figure through Dec 2025 stood at -$943000.0 (down 209.18% YoY), while the FY2025 annual figure was -$834000.0, down 192.63% from the prior year.
- Other Working Capital Changes improved to -$16000.0 in Q4 2025 per PLUR's latest filing, from -$88000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.2 million in Q4 2022 and bottomed at -$1.3 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged -$21450.0 across 5 years, with a median of -$2000.0 in 2021.
- On a YoY basis, Other Working Capital Changes climbed as much as 313.04% in 2025 and fell as far as 287.23% in 2025.
- Pluri's Other Working Capital Changes stood at -$116000.0 in 2023, then surged by 63.79% to -$42000.0 in 2024, then jumped by 61.9% to -$16000.0 in 2025.
- Business Quant data shows PLUR's Other Working Capital Changes at -$16000.0 in Q4 2025, -$88000.0 in Q3 2025, and -$1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -272,000.00 |
| Dec 31, 2025 | -272,000.00 |
| Dec 31, 2025 | -272,000.00 |
| Sep 30, 2025 | 659,000.00 |
| Sep 30, 2025 | 659,000.00 |
| Sep 30, 2025 | 659,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | -295,000.00 |
| Dec 31, 2024 | -295,000.00 |
| Dec 31, 2024 | -295,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -80,000.00 |